These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2684039)

  • 21. The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.
    Lennard L; Lilleyman JS; Maddocks JL
    Br J Cancer; 1986 Jan; 53(1):115-9. PubMed ID: 3456241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
    Veerman AJ; Hählen K; Kamps WA; Van Leeuwen EF; De Vaan GA; Solbu G; Suciu S; Van Wering ER; Van der Does-Van der Berg A
    J Clin Oncol; 1996 Mar; 14(3):911-8. PubMed ID: 8622039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
    Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
    Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelosuppressive effect of colaspase (L-asparaginase) in initial treatment of acute lymphoblastic leukaemia.
    Johnston PG; Hardisty RM; Kay HE; Smith PG
    Br Med J; 1974 Jul; 3(5923):81-3. PubMed ID: 4604804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
    Chessells JM; Richards SM; Bailey CC; Lilleyman JS; Eden OB
    Br J Haematol; 1995 Feb; 89(2):364-72. PubMed ID: 7873387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute lymphoblastic leukaemia: effect of variation in length of treatment on duration of remission. Report to the Medical Research Council by the Working Party on Leukaemia in Childhood.
    Br Med J; 1977 Aug; 2(6085):495-7. PubMed ID: 329946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Children under two years treated according to the Medical Research Council UKALL VIII study and trial 1980-1984 (on behalf of the Medical Research Council Working Party on Leukaemia in Childhood).
    Eden OB; Shaw MP; Lilleyman JS; Richards S
    Br J Cancer Suppl; 1992 Aug; 18():S58-62. PubMed ID: 1503928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
    Steinherz PG; Gaynon P; Miller DR; Reaman G; Bleyer A; Finklestein J; Evans RG; Meyers P; Steinherz LJ; Sather H
    J Clin Oncol; 1986 May; 4(5):744-52. PubMed ID: 3517244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
    Eden OB; Harrison G; Richards S; Lilleyman JS; Bailey CC; Chessells JM; Hann IM; Hill FG; Gibson BE
    Leukemia; 2000 Dec; 14(12):2307-20. PubMed ID: 11187922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of 6-mercaptopurine dose in lymphoblastic leukaemia.
    Hale JP; Lilleyman JS
    Arch Dis Child; 1991 Apr; 66(4):462-6. PubMed ID: 2031601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III: the effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL.
    Med Pediatr Oncol; 1982; 10(5):501-10. PubMed ID: 6755207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
    Lilleyman JS; Hann IM; Stevens RF; Richards SM; Eden OB; Chessells JM; Bailey CC
    Br J Haematol; 1992 May; 81(1):52-7. PubMed ID: 1520624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6-Mercaptopurine dose escalation and its effect on drug tolerance in childhood lymphoblastic leukaemia.
    Welch JC; Lilleyman JS
    Cancer Chemother Pharmacol; 1996; 38(1):113-6. PubMed ID: 8603445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
    Koren G; Ferrazini G; Sulh H; Langevin AM; Kapelushnik J; Klein J; Giesbrecht E; Soldin S; Greenberg M
    N Engl J Med; 1990 Jul; 323(1):17-21. PubMed ID: 2355954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey CC; Richards S
    Leukemia; 1992; 6 Suppl 2():157-61. PubMed ID: 1578921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate.
    Schmiegelow K; Pulczynska MK; Seip M
    Pediatr Hematol Oncol; 1988; 5(4):259-67. PubMed ID: 3152971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?
    Schmiegelow K; Nersting J; Nielsen SN; Heyman M; Wesenberg F; Kristinsson J; Vettenranta K; Schrøeder H; Weinshilboum R; Jensen KL; Grell K; Rosthoej S
    Pediatr Blood Cancer; 2016 Dec; 63(12):2104-2111. PubMed ID: 27447547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. French American British (FAB) morphological classification of childhood lymphoblastic leukaemia and its clinical importance.
    Lilleyman JS; Hann IM; Stevens RF; Eden OB; Richards SM
    J Clin Pathol; 1986 Sep; 39(9):998-1002. PubMed ID: 3463568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period.
    Marcus RE; Catovsky D; Johnson SA; Gregory WM; Talavera JG; Goldman JM; Galton DA
    Br J Cancer; 1986 Feb; 53(2):175-80. PubMed ID: 3456786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.